GlassScriptPhysician profile
Antonio Sotolongo
NPI 1255618302
$22,082.53
in general payments reported to CMS, 2019-2025
20 companies · $4,238 in 2025
The $4,238 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,082 · 2020: $427 · 2021: $755 · 2022: $2,852 · 2023: $3,265 · 2024: $2,463 · 2025: $4,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,048 · Travel and Lodging: $1,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,048.17 |
| Travel and Lodging | $1,917.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,080.57 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic Vascular, INC. | $5,144.59 | 2019-2020 | |
| Medtronic, INC. | $4,412.50 | 2019-2025 | Micra, Selectsecure, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $2,544.08 | 2019-2025 | Carto 3, Soundstar |
| Boston Scientific Corporation | $1,718.26 | 2019-2025 | Watchman Flx, Sq-Rx Pulse Generator, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.23 | 2019-2025 | Lifevest |
| Abiomed | $115.55 | 2022-2025 | Impella |
| Pfizer INC. | $103.92 | 2019-2025 | |
| Vektor Medical INC. | $101.21 | 2025 | Vmap |
| E.R. Squibb & Sons, L.L.C. | $99.24 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $80.71 | 2024-2025 | |
| Atricure, INC. | $69.54 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $68.25 | 2022-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $55.52 | 2019-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $54.18 | 2025 | Mynx Control, Mynx Control Venous |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $41.40 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $30.12 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $17.52 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.15 | 2024 | Xarelto |
| Convatec INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Sotolongo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.